Since April 2024, there have been 70 confirmed human infections of H5N1 bird flu, alongside one fatality, as reported by the CDC. The general risk to the public remains low, although individuals in contact with infected animals or contaminated environments face moderate to high risks. Recent genetic sequencing revealed significant mutations in the virus that improve replication efficiency in mammals. Importantly, while mutations exist, they do not affect antiviral treatments or vaccines. Continued monitoring is essential as these developments unfold.
The CDC has reported 70 confirmed H5N1 bird flu infections in humans, with a low general population risk, while at-risk individuals face a moderate to high risk.
Genetically sequenced viruses from human infections show mutations linked to more efficient mammal and human viral replication, raising concerns over future risks.
Collection
[
|
...
]